ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.732
EU - Europa 1.177
AS - Asia 1.078
SA - Sud America 162
AF - Africa 18
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.172
Nazione #
US - Stati Uniti d'America 2.682
CN - Cina 387
PL - Polonia 367
SG - Singapore 330
UA - Ucraina 177
DE - Germania 172
BR - Brasile 147
HK - Hong Kong 135
IT - Italia 130
FI - Finlandia 90
VN - Vietnam 79
GB - Regno Unito 69
TR - Turchia 40
IE - Irlanda 34
RU - Federazione Russa 34
CA - Canada 30
FR - Francia 29
IN - India 23
SE - Svezia 17
BD - Bangladesh 16
ID - Indonesia 12
ES - Italia 11
MX - Messico 10
NL - Olanda 10
AR - Argentina 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
PK - Pakistan 7
ZA - Sudafrica 7
BG - Bulgaria 6
JP - Giappone 6
KR - Corea 6
AT - Austria 5
BE - Belgio 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
KG - Kirghizistan 4
NI - Nicaragua 4
SA - Arabia Saudita 4
TW - Taiwan 4
UZ - Uzbekistan 4
CL - Cile 2
CR - Costa Rica 2
EC - Ecuador 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 5.172
Città #
Warsaw 367
Fairfield 332
Ashburn 246
Woodbridge 234
Singapore 175
Houston 174
Seattle 169
Chandler 141
Jacksonville 133
Cambridge 117
Hong Kong 117
Wilmington 105
New York 102
Ann Arbor 93
Dearborn 92
Beijing 81
Los Angeles 66
Princeton 62
Helsinki 58
Nanjing 41
Brescia 37
Munich 36
Dublin 34
Istanbul 31
Shanghai 30
Des Moines 25
San Francisco 24
The Dalles 23
Dallas 21
Dong Ket 20
Jinan 20
São Paulo 20
Chicago 19
Buffalo 17
Shenyang 16
Toronto 16
London 15
Ho Chi Minh City 14
Milan 14
Turku 14
Central 13
Changsha 13
Hanoi 12
Moscow 12
Nanchang 12
Hangzhou 11
Hebei 11
Santa Clara 11
Kunming 10
Belo Horizonte 9
Jiaxing 9
Rome 9
Stockholm 9
Tianjin 9
Denver 8
Jakarta 8
Poplar 8
Redondo Beach 8
San Diego 8
Ankara 7
Guangzhou 7
Boston 6
Brooklyn 6
Chennai 6
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Orem 6
Phoenix 6
Zhengzhou 6
Brno 5
Brussels 5
Hefei 5
Mexico City 5
Norwalk 5
Sofia 5
Tokyo 5
Atlanta 4
Bishkek 4
Cazzago San Martino 4
Johannesburg 4
Lahore 4
Leawood 4
Managua 4
Manchester 4
Milton Keynes 4
Montreal 4
Mumbai 4
Nardò 4
Ningbo 4
Paris 4
Porto Alegre 4
Tashkent 4
Vienna 4
Amsterdam 3
Biên Hòa 3
Campinas 3
Charlotte 3
Curitiba 3
Desio 3
Totale 3.730
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 329
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 314
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 265
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 198
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 188
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 182
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 176
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 176
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 174
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 172
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 168
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 168
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 164
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 163
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 161
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 157
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 156
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 149
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 145
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 143
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 137
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 135
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 125
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 123
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 117
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 109
Oxide nanobelts as conductometric gas sensors 108
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 101
Gas sensitive light emission properties of tin oxide nanobelts 97
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 91
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 84
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 78
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 58
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 42
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 19
Totale 5.260
Categoria #
all - tutte 23.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021457 0 0 0 0 0 55 35 80 62 121 64 40
2021/2022337 43 59 5 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/2026963 165 166 110 231 209 82 0 0 0 0 0 0
Totale 5.260